These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols. Meenach SA, Vogt FG, Anderson KW, Hilt JZ, McGarry RC, Mansour HM. Int J Nanomedicine; 2013; 8():275-93. PubMed ID: 23355776 [Abstract] [Full Text] [Related]
3. High-performing dry powder inhalers of paclitaxel DPPC/DPPG lung surfactant-mimic multifunctional particles in lung cancer: physicochemical characterization, in vitro aerosol dispersion, and cellular studies. Meenach SA, Anderson KW, Hilt JZ, McGarry RC, Mansour HM. AAPS PharmSciTech; 2014 Dec; 15(6):1574-87. PubMed ID: 25139763 [Abstract] [Full Text] [Related]
4. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols. Park CW, Li X, Vogt FG, Hayes D, Zwischenberger JB, Park ES, Mansour HM. Int J Pharm; 2013 Oct 15; 455(1-2):374-92. PubMed ID: 23820131 [Abstract] [Full Text] [Related]
5. Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery. Gomez AI, Acosta MF, Muralidharan P, Yuan JX, Black SM, Hayes D, Mansour HM. Pulm Pharmacol Ther; 2020 Oct 15; 64():101975. PubMed ID: 33137515 [Abstract] [Full Text] [Related]
14. Preparation and Characterization of Spray-Dried Inhalable Powders Containing Polymeric Micelles for Pulmonary Delivery of Paclitaxel in Lung Cancer. Rezazadeh M, Davatsaz Z, Emami J, Hasanzadeh F, Jahanian-Najafabadi A. J Pharm Pharm Sci; 2018 Jun 15; 21(1s):200s-214s. PubMed ID: 30321135 [Abstract] [Full Text] [Related]
15. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying. Lu W, Rades T, Rantanen J, Yang M. Int J Pharm; 2019 Jun 30; 565():1-8. PubMed ID: 30999050 [Abstract] [Full Text] [Related]
16. Assessment of Dry Powder Inhaler Carrier Targeted Design: A Comparative Case Study of Diverse Anomeric Compositions and Physical Properties of Lactose. Pinto JT, Zellnitz S, Guidi T, Roblegg E, Paudel A. Mol Pharm; 2018 Jul 02; 15(7):2827-2839. PubMed ID: 29856921 [Abstract] [Full Text] [Related]